• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用术中分子诊断的低级别胶质瘤手术策略。

A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis.

机构信息

Department of Neurosurgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Faculty of Advanced Techno-Surgery, Graduate School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Brain Tumor Pathol. 2018 Jul;35(3):159-167. doi: 10.1007/s10014-018-0324-1. Epub 2018 Jul 6.

DOI:10.1007/s10014-018-0324-1
PMID:29980868
Abstract

Lower grade gliomas are both treated and diagnosed via surgical resection. Maximum tumor resection is currently the standard of care; however, this risks the loss of brain function. Glioma can be genetically subdivided into three different types, based on isocitrate dehydrogenase (IDH) mutation status and the presence of 1p/19q codeletion, which have radically different prognoses and responses to adjuvant therapies. Therefore, the means to identify the subtype and evaluate the surrounding tissues during surgery would be advantageous. In this study, we have developed a new surgical strategy for lower grade glioma based on the fourth edition of the World Health Organization Brain Tumor Classification, involving intraoperative molecular diagnosis. High-resolution melting analysis was used to evaluate IDH mutational status, while rapid immunohistochemistry of p53 and alpha-thalassemia/mental retardation syndrome X-linked (ATRX) was used to evaluate the 1p/19q codeletion status, allowing genetic classification during surgery. In addition, intraoperative flow cytometry was used to evaluate the surgical cavity for additional tumor lesions, allowing maximal resection while mitigating the risk of functional losses. This strategy allows the rapid intraoperative diagnosis and mapping of lower grade gliomas, and its clinical use could dramatically improve its prognosis.

摘要

低级别胶质瘤通过手术切除进行治疗和诊断。最大限度地切除肿瘤是目前的标准治疗方法;然而,这有丧失脑功能的风险。根据异柠檬酸脱氢酶 (IDH) 突变状态和 1p/19q 缺失情况,胶质瘤可在基因上分为三种不同类型,它们具有截然不同的预后和对辅助治疗的反应。因此,在手术过程中识别亚型和评估周围组织的方法将是有利的。在这项研究中,我们根据世界卫生组织第四版脑肿瘤分类制定了一种新的低级别胶质瘤手术策略,涉及术中分子诊断。高分辨率熔解分析用于评估 IDH 突变状态,而 p53 和 α-地中海贫血/智力迟钝综合征 X 连锁(ATRX)的快速免疫组织化学用于评估 1p/19q 缺失状态,允许在手术过程中进行遗传分类。此外,术中流式细胞术用于评估手术腔中的其他肿瘤病变,允许最大限度地切除肿瘤,同时降低功能丧失的风险。这种策略允许快速进行术中诊断和绘制低级别胶质瘤图谱,其临床应用可能会显著改善其预后。

相似文献

1
A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis.利用术中分子诊断的低级别胶质瘤手术策略。
Brain Tumor Pathol. 2018 Jul;35(3):159-167. doi: 10.1007/s10014-018-0324-1. Epub 2018 Jul 6.
2
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.IDH 1/2 突变且无 1p/19q 共缺失的 WHO Ⅲ级胶质瘤患者行全切除的影响
J Neurooncol. 2016 Sep;129(3):505-514. doi: 10.1007/s11060-016-2201-2. Epub 2016 Jul 11.
3
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.异柠檬酸脱氢酶(IDH)突变、1p/19q 缺失及磷酸酶和张力蛋白同源物(PTEN)缺失分析可明确临床低级别弥漫性胶质瘤的预后。
Neuro Oncol. 2014 Jul;16(7):914-23. doi: 10.1093/neuonc/not299.
4
RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.基于 RNA 编辑的弥漫性神经胶质瘤分类:预测异柠檬酸脱氢酶突变和染色体 1p/19q 联合缺失。
BMC Bioinformatics. 2019 Dec 24;20(Suppl 19):659. doi: 10.1186/s12859-019-3236-0.
5
Prediction of -Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.术前磁共振成像表型预测低级别胶质瘤中的 -突变和 1p/19q 缺失状态。
AJNR Am J Neuroradiol. 2018 Jan;39(1):37-42. doi: 10.3174/ajnr.A5421. Epub 2017 Nov 9.
6
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.世界卫生组织二级胶质瘤中的异柠檬酸脱氢酶(IDH)突变、1p19q共缺失和α-地中海贫血/智力发育障碍综合征X连锁基因(ATRX)缺失
Oncotarget. 2015 Oct 6;6(30):30295-305. doi: 10.18632/oncotarget.4497.
7
Impact of 1p/19q codeletion status on extent of resection in WHO grade II glioma: Insights from a national cancer registry.1p/19q共缺失状态对世界卫生组织II级胶质瘤切除范围的影响:来自国家癌症登记处的见解
Clin Neurol Neurosurg. 2019 Jul;182:32-36. doi: 10.1016/j.clineuro.2019.04.027. Epub 2019 Apr 30.
8
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH.下一代测序 panel 用于 1p/19q 共缺失和 IDH1-IDH2 突变分析,揭示了 FISH 对 1p/19q 共缺失的误诊。
J Mol Diagn. 2021 Sep;23(9):1185-1194. doi: 10.1016/j.jmoldx.2021.06.004. Epub 2021 Jun 26.
9
MRI and CT Identify Isocitrate Dehydrogenase -Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.MRI 和 CT 可识别异柠檬酸脱氢酶突变型低级别胶质瘤,这些肿瘤通过荧光原位杂交被错误分类为 1p/19q 缺失状态。
Radiology. 2020 Jan;294(1):160-167. doi: 10.1148/radiol.2019191140. Epub 2019 Nov 12.
10
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.高级影像学参数可提高弥漫性低级别胶质瘤 IDH 突变型无 1p19q 联合缺失亚型的预测准确性:T2/FLAIR 不匹配征象的附加价值。
Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24.

引用本文的文献

1
Pushing the boundaries of neurosurgical oncology: evaluating the superiority of supratotal resection over gross total resection in intraoperative MRI-guided glioma surgery.突破神经外科肿瘤学的界限:评估术中磁共振成像引导的胶质瘤手术中超全切除相对于全切除的优势。
Neurosurg Rev. 2025 Feb 6;48(1):200. doi: 10.1007/s10143-025-03301-x.
2
Implications of molecular classifications in glioma surgery.分子分类在胶质瘤手术中的意义
J Neurooncol. 2025 Feb;171(3):559-569. doi: 10.1007/s11060-024-04883-0. Epub 2024 Nov 12.
3
CircSOBP suppresses the progression of glioma by disrupting glycolysis and promoting the MDA5-mediated immune response.
环状SOBP通过破坏糖酵解和促进MDA5介导的免疫反应来抑制胶质瘤的进展。
iScience. 2023 Sep 13;26(10):107897. doi: 10.1016/j.isci.2023.107897. eCollection 2023 Oct 20.
4
Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis.世界卫生组织3级胶质瘤切除范围决策系统:一项中国胶质瘤基因组图谱数据库分析
J Neurooncol. 2023 Sep;164(2):461-471. doi: 10.1007/s11060-023-04420-5. Epub 2023 Sep 5.
5
Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing.通过实时靶向扩增子测序进行超快速体突变检测。
Commun Biol. 2022 Jul 15;5(1):708. doi: 10.1038/s42003-022-03657-6.
6
The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.FDG-PET 中低葡萄糖摄取对 IDH1 突变型脑胶质瘤的诊断价值。
BMC Cancer. 2021 Jan 20;21(1):83. doi: 10.1186/s12885-021-07797-6.
7
Role of molecular biomarkers in glioma resection: a systematic review.分子生物标志物在胶质瘤切除中的作用:一项系统综述
Chin Neurosurg J. 2020 May 18;6:18. doi: 10.1186/s41016-020-00198-x. eCollection 2020.
8
Reliability of Residual Tumor Estimation Based on Navigation Log.基于导航日志的残余肿瘤估计的可靠性。
Neurol Med Chir (Tokyo). 2020 Sep 15;60(9):458-467. doi: 10.2176/nmc.oa.2020-0042. Epub 2020 Aug 15.
9
Prediction of lower-grade glioma molecular subtypes using deep learning.使用深度学习预测低级别胶质瘤的分子亚型。
J Neurooncol. 2020 Jan;146(2):321-327. doi: 10.1007/s11060-019-03376-9. Epub 2019 Dec 21.